A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol.

By Ethan B. Russo, G. Guy. Medical Hypotheses, 2006

597 citations recorded by the source corpus.

Subfields: Clinical Psychology, Pharmacology, Toxicology

View Paper: https://www.semanticscholar.org/paper/8ce3c8b41d1408bd4b8ad98351229c7ea70b888c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Clinical Psychology

1. V. Di Marzo

In Pharmacology

1. V. Di Marzo
2. George Kunos
3. P. Pacher
4. S. Batkai

In Toxicology

1. George Kunos
2. V. Di Marzo

Citations in the corpus

• The Endocannabinoid System as an Emerging Target of Pharmacotherapy (2006, background): “Delivery of cannabis-based extracts as an oromucosal spray may minimize these drawbacks and may allow patients to better optimize their individual daily dose by selftitration (Russo, 2006).”
• Effects of cannabinoids and cannabinoid‐enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes (2011, background): “approximate 1:1 ratio of THC- and CBD-enriched Cannabis extracts, which was suggested to exhibit a higher therapeutic index than the corresponding pure cannabinoids (Russo and Guy, 2006).”
• Targeting the endocannabinoid system: to enhance or reduce? (2008, background): “jpg" NDATA ITEM> ]> Owing to its psychotropic and medicinal effects, Cannabis sativa has been mankind's friend and foe for millenni”